Glutathione s transferases (GSTs) - Cancer Science

Glutathione S-Transferases (GSTs) are a group of enzymes involved in the detoxification of endogenous and exogenous compounds. They catalyze the conjugation of the antioxidant glutathione to various electrophilic compounds, facilitating their removal from the body. GSTs are expressed in many tissues and have a crucial role in cellular defense mechanisms.
GSTs are implicated in cancer due to their role in detoxifying carcinogens and other harmful compounds. Overexpression of certain GST isoforms can contribute to chemoresistance by detoxifying chemotherapeutic agents, thereby reducing their efficacy. On the other hand, some polymorphisms in GST genes are associated with an increased risk of developing various forms of cancer.
The GST family is divided into several classes, including Alpha, Mu, Pi, Theta, and Omega. Among these, GSTP1 (Pi class) is the most studied in the context of cancer. GSTP1 is often overexpressed in tumors and is linked to resistance to multiple chemotherapy drugs. Other isoforms, such as GSTA1 and GSTM1, also play significant roles in cancer biology.
Yes, GSTs can serve as potential biomarkers for cancer prognosis and treatment response. For instance, elevated levels of GSTP1 can indicate poor prognosis and resistance to chemotherapy in certain cancers like prostate cancer and breast cancer. Additionally, GST polymorphisms can serve as genetic markers for cancer susceptibility.
Researchers are exploring various strategies to inhibit GST activity as a means to enhance chemotherapy efficacy. GST inhibitors, such as ethacrynic acid, have shown potential in preclinical studies. Additionally, targeting GSTs with siRNA or other gene-silencing technologies is being investigated to overcome drug resistance in cancer cells.
Ongoing research aims to better understand the complex role of GSTs in cancer biology. Advances in precision medicine and personalized therapy may allow for more tailored approaches in targeting GSTs. Combining GST inhibitors with conventional chemotherapy could potentially improve treatment outcomes for patients with drug-resistant cancers.



Relevant Publications

Partnered Content Networks

Relevant Topics